Cart

News & Science

Nerve regeneration following 12-months of omega-3 nutrition therapy in patients with type 1 diabetes

Nerve regeneration following 12-months of omega-3 nutrition therapy in patients with type 1 diabetes

2021-05-27

Participants with T1D took seal-oil (10 mL/day; 750 mg eicosapentaenoic acid (EPA), 560 mg docosapentaenoic acid (DPAn-3), and 1020 mg docosahexaenoic acid (DHA)) for 12-months in a single-arm open-label study. Twelve-months seal-oil therapy increased mean plasma EPA by 185%, DPA by 29%, DHA by 79% (p < 0.001) and CNFL by 29% (p = 0.001). In conclusion, low plasma DHA was associated with prevalent DSP, n-3 therapy increased blood n-3 levels and higher baseline n-3s were associated with greater nerve regeneration.
Omega-3 fatty acids in the psychological and physiological resilience against COVID-19

Omega-3 fatty acids in the psychological and physiological resilience against COVID-19

2021-02-16

Improving innate immunity has been suggested to block progression of COVID-19 at early stages, while omega-3 polyunsaturated fatty acids (n-3 PUFAs) have been shown to have immunomodulation effects. Moreover, n-3 PUFAs have also been shown to improve mood disorders.
May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?

May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?

2021-01-18

Omega-3 long-chain polyunsaturated fatty acids (omega-3 LC-PUFAs) could help improve the resolution of the inflammatory balance, limiting therefore the level and duration of the critical inflammatory period. Omega-3 LC-PUFAs may also interact at different stages of the viral infection, notably on the virus entry and replication.
Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study

Different metabolism of EPA, DPA and DHA in humans: A double-blind cross-over study

2020-11-30

The findings showed that DPA as a reservoir could be metabolized into DHA, and further retro-conversed back to EPA. Supplementation with EPA was efficiently incorporated into plasma lipid fractions, whereas incorporation of DHA into plasma lipid fractions was limited within a short period of supplement.
Effect of omega-3 supplementation on neuropathy in type 1 diabetes - A 12-month pilot trial

Effect of omega-3 supplementation on neuropathy in type 1 diabetes - A 12-month pilot trial

2020-10-28

12 months of seal oil omega-3 polyunsaturated fatty acids (v-3 PUFA) supplementation will stop the known progression of diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes mellitus (T1DM).
Association between Obesity and Omega-3 Status in Healthy Young Women

Association between Obesity and Omega-3 Status in Healthy Young Women

2020-10-01

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are essential for healthy development and protect against metabolic disease. However, individuals with obesity may be pre-disposed to experiencing lower n-3 PUFA status than normal-weight individuals.

Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus

Omega-3 Fatty Acid Supplementation Linked to Reduced Inflammation and Flaring in Lupus

2020-09-04

Preclinical and clinical studies reveal that consumption of the marine ω-3 highly unsaturated fatty acids (HUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) might be used as a precision nutrition intervention to lessen lupus symptoms. 
Higher levels of omega-3s are associated with lower risk of suboptimal sleep

Higher levels of omega-3s are associated with lower risk of suboptimal sleep

2020-08-04

Research: participant ages ranged from 35 to 96 years from 5 countries (Finland, Iceland, Sweden, Singapore, and the United States) with higher circulating omega-3 FAs had a lower risk of suboptimal sleep.

Potential benefits of omega-3 supplementation to patients with COVID-19

Potential benefits of omega-3 supplementation to patients with COVID-19

2020-07-16

Omega-3 dietary supplements could possibly improve the COVID-19 patient's recovery. Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), present an anti-inflammatory effect that could ameliorate some patients need for intensive care unit (ICU) admission
Powered by Shopify